quinazolines has been researched along with oxadiazoles in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (10.53) | 18.7374 |
| 1990's | 2 (10.53) | 18.2507 |
| 2000's | 2 (10.53) | 29.6817 |
| 2010's | 12 (63.16) | 24.3611 |
| 2020's | 1 (5.26) | 2.80 |
| Authors | Studies |
|---|---|
| Baktir, G; Büyüktimkin, S; Capan, G; Ergenç, N; Rollas, S | 1 |
| Agarwal, VK; Barthwal, JP; Dixit, KS; Parmar, SS; Tandon, SK | 1 |
| Amico-Roxas, M; Bitetti, R; Russo, A; Russo, F; Santagati, A; Santagati, M | 1 |
| Rao, AR; Reddy, VM | 1 |
| Boon, K; Fooks, HM; Hourani, SM; Prentice, DJ | 1 |
| Carvalho, LC; de Moura, RS; Madeira, SV; Miranda, DZ; Pinto, AC; Rangel, BM; Resende, AC; Rubenich, LM; Sicca, RF; Souza, MA; Tano, T | 1 |
| Bibian, M; Blayo, AL; El Habnouni, S; Fehrentz, JA; Martinez, J; Moulin, A | 1 |
| Hussar, DA | 1 |
| Boddapati, S; Gray, JW; Iacovides, DC; Johnson, AB; Korkola, J; Wang, N | 1 |
| Angelini, M; Benaiteau, F; Fleury, F; Gyulkhandanyan, A; Gyulkhandanyan, L; Le Béchec, M; Lecocq, MF; Logé, C; Reiter, E; Roussakis, C; Rousseau, B; Sakanyan, V | 1 |
| Ding, K; Han, C; Huang, Z; Ji, H; Lai, Y; Peng, S; Wan, L; Zhang, Y | 1 |
| Khanmiri, RH; Moghimi, A; Ng, SW; Shaabani, A; Valizadeh, H | 1 |
| He, C; He, J; Wei, S; Xie, M | 1 |
| El Ashry, ESH; Hagar, M; Ibid, F; Soliman, SM | 1 |
| Bayani, N; Billig, J; Collisson, EA; Cooper, B; Esch, A; Feiler, H; Gray, JW; Griffith, OL; Heiser, M; Hung, JL; Itani, S; Jakkula, L; Korkola, JE; Kuo, WL; Lu, Y; Mills, GB; Mukherjee, S; Oates, C; Spellman, PT; Thompson, W; Tomlin, C; Wang, NJ; Ziyad, S | 1 |
| Boezio, AA; Deak, HL; Emkey, R; Gavva, NR; Geuns-Meyer, S; Graceffa, RF; Gunaydin, H; Guzman-Perez, A; Lee, JH; Lehto, SG; Olivieri, PR; Schenkel, LB; Teffera, Y; Wang, W; Youngblood, BD; Yu, VL; Zhang, M | 1 |
| Chen, L; Liu, M; Wang, M; Wang, X; Xue, W; Yan, J; Zhang, J | 1 |
| Cao, W; Chen, L; Deng, X; Fan, J; Li, Y; Ma, J; Wang, Y; Zeng, G; Zhou, Y | 1 |
| Komander, M; Kudelko, A; Werłos, M; Wołek, B | 1 |
1 review(s) available for quinazolines and oxadiazoles
| Article | Year |
|---|---|
Synthesis of 3,4,5-trisubstituted-1,2,4-triazoles.
Topics: Amides; Hydrazones; Oxadiazoles; Oxazolone; Quinazolines; Thioamides; Triazoles | 2010 |
18 other study(ies) available for quinazolines and oxadiazoles
| Article | Year |
|---|---|
Quinazolinones. 19. Communication [1]: synthesis and evaluation of some CNS depressant properties of 3-(2-[(5-aryl-1,3,4-oxadiazole-2-yl)amino]acetamido)-2-methyl-4 (3H)-quinazolinones.
Topics: Animals; Anticonvulsants; Central Nervous System Depressants; Female; Male; Mice; Motor Activity; Oxadiazoles; Pentylenetetrazole; Quinazolines | 1991 |
Relationship between CNS depressant and enzyme inhibitory properties of substituted quinazolone 1,3,4-oxadiazoles.
Topics: Analgesics; Animals; Anticonvulsants; Central Nervous System; Chemical Phenomena; Chemistry; Cholinesterase Inhibitors; Depression, Chemical; Esters; Hydrazines; In Vitro Techniques; Lethal Dose 50; Mice; Monoamine Oxidase Inhibitors; ortho-Aminobenzoates; Oxadiazoles; Quinazolines; Rats; Reserpine; Thiosemicarbazones | 1973 |
[Chemical and pharmacological research on derivatives of 2,7-substituted 5H-1,3,4-thia(oxa)diazol[2,3-b]quinazolin-5-one].
Topics: Animals; Anti-Inflammatory Agents; Chemical Phenomena; Chemistry; Male; Oxadiazoles; Quinazolines; Rats; Thiadiazoles | 1981 |
Synthesis of N-heteryl-beta-[(2-alkoxyethyl)oxy]/beta-[[2-(N,N- dialkylamino)ethyl]oxy]acetamides as possible H1-antihistaminics.
Topics: Acetamides; Animals; Guinea Pigs; Histamine H1 Antagonists; Hydroquinones; Oxadiazoles; Quinazolines; Thiadiazoles | 1994 |
Role of cyclic nucleotides in vasodilations of the rat thoracic aorta induced by adenosine analogues.
Topics: 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Acetylcholine; Adenine; Adenosine; Adenosine-5'-(N-ethylcarboxamide); Adenylyl Cyclase Inhibitors; Animals; Aorta, Thoracic; Dose-Response Relationship, Drug; Enzyme Inhibitors; In Vitro Techniques; Male; Nitroprusside; Nucleotides, Cyclic; Oxadiazoles; Purinones; Quinazolines; Quinoxalines; Rats; Rats, Wistar; Vasodilation; Vasodilator Agents | 2001 |
Mechanism of the endothelium-dependent vasodilation and the antihypertensive effect of Brazilian red wine.
Topics: Acetylcholine; Administration, Oral; Alcohol Drinking; Animals; Apamin; Atropine; Blood Pressure; Bradykinin; Brazil; Charybdotoxin; Clonidine; Deoxycholic Acid; Drug Therapy, Combination; Endothelium, Vascular; Flavonoids; Glyburide; Guanylate Cyclase; Hypertension; Indomethacin; Male; Mesenteric Arteries; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitroglycerin; Norepinephrine; Oxadiazoles; Perfusion; Phenols; Polyphenols; Potassium Chloride; Pressure; Pyrilamine; Quinazolines; Quinoxalines; Rats; Rats, Wistar; Vasoconstriction; Vasodilation; Wine; Yohimbine | 2004 |
New drugs 2012 part I.
Topics: Aminopyridines; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Benzamides; Benzazepines; Benzimidazoles; Benzofurans; Ceftaroline; Cephalosporins; Cyclopropanes; Drug Approval; Drug Combinations; Humans; Imidazoles; Indoles; Isoindoles; Linagliptin; Lurasidone Hydrochloride; Macrolides; Oxadiazoles; Piperazines; Proline; Purines; Quinazolines; Thiazoles; United States; Vilazodone Hydrochloride | 2012 |
Identification and quantification of AKT isoforms and phosphoforms in breast cancer using a novel nanofluidic immunoassay.
Topics: Breast Neoplasms; Cell Line, Tumor; Electrophoresis, Capillary; Female; Humans; Immunoassay; Isoenzymes; Lapatinib; Metabolic Networks and Pathways; Microfluidic Analytical Techniques; Nanotechnology; Oxadiazoles; Phosphorylation; Protein Kinase Inhibitors; Proteomics; Proto-Oncogene Proteins c-akt; Quinazolines | 2013 |
Screening and discovery of nitro-benzoxadiazole compounds activating epidermal growth factor receptor (EGFR) in cancer cells.
Topics: Cell Line, Tumor; Enzyme Activation; Enzyme Inhibitors; ErbB Receptors; Humans; Neoplasms; Nitro Compounds; Oxadiazoles; Phosphorylation; Quinazolines; Signal Transduction; Tyrphostins | 2014 |
Synthesis and evaluation of 2-anilinopyrimidines bearing 3-aminopropamides as potential epidermal growth factor receptor inhibitors.
Topics: Antineoplastic Agents; Cell Line; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; ErbB Receptors; Gefitinib; Humans; Molecular Structure; Nitric Oxide; Oxadiazoles; Pyrimidines; Quinazolines; Signal Transduction; Structure-Activity Relationship | 2014 |
Diaminoglyoxime as a versatile reagent in the synthesis of bis(1,2,4-oxadiazoles), 1,2,4-oxadiazolyl-quinazolines and 1,2,4-oxadiazolyl-benzothiazinones.
Topics: Chemistry Techniques, Synthetic; Models, Molecular; Molecular Structure; Oxadiazoles; Oximes; Quinazolines | 2014 |
γ Secretase inhibitor BMS-708163 reverses resistance to EGFR inhibitor via the PI3K/Akt pathway in lung cancer.
Topics: Amyloid Precursor Protein Secretases; Animals; Apoptosis; Cell Line, Tumor; Cell Survival; ErbB Receptors; Female; Gefitinib; Immunohistochemistry; Lung Neoplasms; Mice; Mice, Inbred BALB C; Oxadiazoles; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Quinazolines; Sulfonamides | 2015 |
Experimental and theoretical spectroscopic studies, HOMO-LUMO, NBO analyses and thione-thiol tautomerism of a new hybrid of 1,3,4-oxadiazole-thione with quinazolin-4-one.
Topics: Electrons; Magnetic Resonance Spectroscopy; Molecular Conformation; Nonlinear Dynamics; Optical Phenomena; Oxadiazoles; Quinazolines; Quinazolinones; Static Electricity; Stereoisomerism; Sulfhydryl Compounds; Thermodynamics; Thiones; Vibration | 2015 |
Decoupling of the PI3K Pathway via Mutation Necessitates Combinatorial Treatment in HER2+ Breast Cancer.
Topics: Antineoplastic Agents; Cell Line, Tumor; Class I Phosphatidylinositol 3-Kinases; Diamines; Drug Resistance, Neoplasm; Epithelial Cells; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Lapatinib; Mammary Glands, Human; Mutation; Oxadiazoles; Phosphatidylinositol 3-Kinases; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Pyrazoles; Quinazolines; Receptor, ErbB-2; Ribosomal Protein S6; Signal Transduction | 2015 |
Optimization of a Novel Quinazolinone-Based Series of Transient Receptor Potential A1 (TRPA1) Antagonists Demonstrating Potent in Vivo Activity.
Topics: Animals; Biological Transport, Active; Calcium Channels; CHO Cells; Cricetulus; Dogs; Dose-Response Relationship, Drug; Drug Discovery; High-Throughput Screening Assays; Humans; In Vitro Techniques; Madin Darby Canine Kidney Cells; Microsomes, Liver; Models, Molecular; Nerve Tissue Proteins; Oxadiazoles; Pain Measurement; Purines; Quinazolines; Rats; Structure-Activity Relationship; Transient Receptor Potential Channels; TRPA1 Cation Channel | 2016 |
Synthesis and three-dimensional quantitative structure-activity relationship study of quinazoline derivatives containing a 1,3,4-oxadiazole moiety as efficient inhibitors against Xanthomonas axonopodis pv. citri.
Topics: Anti-Bacterial Agents; Chemistry Techniques, Synthetic; Microbial Sensitivity Tests; Models, Molecular; Molecular Conformation; Oxadiazoles; Quantitative Structure-Activity Relationship; Quinazolines; Xanthomonas axonopodis | 2018 |
Dual-targeting Rutaecarpine-NO donor hybrids as novel anti-hypertensive agents by promoting release of CGRP.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Blood Pressure Determination; Calcitonin Gene-Related Peptide; Dose-Response Relationship, Drug; Drug Design; Hypertension; Indole Alkaloids; Male; Molecular Structure; Oxadiazoles; Quinazolines; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Vasodilator Agents | 2019 |
Efficient Synthesis of Novel 1,3,4-Oxadiazoles Bearing a 4-
Topics: Boronic Acids; Carbonates; Catalysis; Chemistry Techniques, Synthetic; Esters; Luminescence; Magnetic Resonance Spectroscopy; Molecular Structure; Oxadiazoles; Palladium; Quinazolines; Solvents; Spectrometry, Fluorescence | 2020 |